163 related articles for article (PubMed ID: 17131336)
1. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
[TBL] [Abstract][Full Text] [Related]
2. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.
Hartmann TB; Bazhin AV; Schadendorf D; Eichmüller SB
Int J Cancer; 2005 Mar; 114(1):88-93. PubMed ID: 15523688
[TBL] [Abstract][Full Text] [Related]
3. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
Usener D; Gerhardt A; Schadendorf D; Eichmüller S
Br J Dermatol; 2003 Aug; 149(2):282-8. PubMed ID: 12932233
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.
Ehlken H; Schadendorf D; Eichmüller S
Int J Cancer; 2004 Jan; 108(2):307-13. PubMed ID: 14639620
[TBL] [Abstract][Full Text] [Related]
5. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
[TBL] [Abstract][Full Text] [Related]
6. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
Lei B; Bush RA; Milam AH; Sieving PA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
8. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
9. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
Milam AH; Saari JC; Jacobson SG; Lubinski WP; Feun LG; Alexander KR
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):91-100. PubMed ID: 8425845
[TBL] [Abstract][Full Text] [Related]
11. Serological detection of cutaneous T-cell lymphoma-associated antigens.
Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
[TBL] [Abstract][Full Text] [Related]
12. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
[TBL] [Abstract][Full Text] [Related]
13. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
[TBL] [Abstract][Full Text] [Related]
14. [Cancer-associated retinopathy].
Ohguro H; Takaya T; Ogawa K; Suzuki J; Nakagawa T
Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):283-7. PubMed ID: 9136565
[TBL] [Abstract][Full Text] [Related]
15. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
[TBL] [Abstract][Full Text] [Related]
16. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
18. Identification of selectively expressed genes and antigens in CTCL.
Hartmann TB; Mattern E; Wiedemann N; van Doorn R; Willemze R; Niikura T; Hildenbrand R; Schadendorf D; Eichmüller SB
Exp Dermatol; 2008 Apr; 17(4):324-34. PubMed ID: 17979976
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated retinopathy: does autoimmunity prolong survival?
Chan C; O'Day J
Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
[TBL] [Abstract][Full Text] [Related]
20. Serological analysis of human renal cell carcinoma.
Devitt G; Meyer C; Wiedemann N; Eichmüller S; Kopp-Schneider A; Haferkamp A; Hautmann R; Zöller M
Int J Cancer; 2006 May; 118(9):2210-9. PubMed ID: 16331622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]